An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Levemir® (Insulin Detemir) in Pregnant Women With Diabetes Mellitus
Sponsor: Novo Nordisk A/S
This observational or N/A phase trial investigates Diabetes Mellitus and Diabetes Mellitus, Type 1 and is currently completed. Novo Nordisk A/S leads this study, which shows 29 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
29 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Dec 2019 — Jan 2021 [monthly]
Completed
▶ Show 24 earlier versions
-
Nov 2019 — Dec 2019 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Oct 2019 — Nov 2019 [monthly]
Active Not Recruiting
-
Sep 2019 — Oct 2019 [monthly]
Active Not Recruiting
-
Aug 2019 — Sep 2019 [monthly]
Active Not Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Active Not Recruiting
-
Jun 2019 — Jul 2019 [monthly]
Active Not Recruiting
-
May 2019 — Jun 2019 [monthly]
Active Not Recruiting
-
Mar 2019 — May 2019 [monthly]
Active Not Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Active Not Recruiting
-
Nov 2018 — Feb 2019 [monthly]
Active Not Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Active Not Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
-
Feb 2018 — Mar 2018 [monthly]
Enrolling By Invitation NA
-
Dec 2017 — Feb 2018 [monthly]
Enrolling By Invitation NA
-
Nov 2017 — Dec 2017 [monthly]
Enrolling By Invitation NA
-
Oct 2017 — Nov 2017 [monthly]
Enrolling By Invitation NA
-
Aug 2017 — Oct 2017 [monthly]
Enrolling By Invitation NA
-
Jun 2017 — Aug 2017 [monthly]
Enrolling By Invitation NA
-
May 2017 — Jun 2017 [monthly]
Enrolling By Invitation NA
-
Mar 2017 — May 2017 [monthly]
Enrolling By Invitation NA
-
Feb 2017 — Mar 2017 [monthly]
Enrolling By Invitation NA
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation NA
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Novo Nordisk A/S
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Almada, Portugal , Alor Gajah, Malaysia , Alor Star, Malaysia , Amadora, Portugal , Amsterdam, Netherlands , Angers, France , Apeldoorn, Netherlands , Arnhem, Netherlands , Athens, Greece , Barcelona, Spain and 70 more locations